Elekta AB (EKTAY)
7.155
-0.09
(-1.26%)
USD |
OTCM |
May 09, 16:00
Elekta Market Cap: 2.734B for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.734B |
| May 08, 2024 | 2.769B |
| May 07, 2024 | 2.772B |
| May 06, 2024 | 2.778B |
| May 03, 2024 | 2.701B |
| May 02, 2024 | 2.684B |
| May 01, 2024 | 2.689B |
| April 30, 2024 | 2.755B |
| April 29, 2024 | 2.738B |
| April 26, 2024 | 2.619B |
| April 25, 2024 | 2.560B |
| April 24, 2024 | 2.644B |
| April 23, 2024 | 2.694B |
| April 22, 2024 | 2.650B |
| April 19, 2024 | 2.571B |
| April 18, 2024 | 2.589B |
| April 17, 2024 | 2.625B |
| April 16, 2024 | 2.663B |
| April 15, 2024 | 2.709B |
| April 12, 2024 | 2.682B |
| April 11, 2024 | 2.795B |
| April 10, 2024 | 2.827B |
| April 09, 2024 | 2.911B |
| April 08, 2024 | 2.987B |
| April 05, 2024 | 2.929B |
| Date | Value |
|---|---|
| April 04, 2024 | 2.957B |
| April 03, 2024 | 2.982B |
| April 02, 2024 | 2.928B |
| April 01, 2024 | 2.895B |
| March 28, 2024 | 2.869B |
| March 27, 2024 | 2.892B |
| March 26, 2024 | 2.890B |
| March 25, 2024 | 2.893B |
| March 22, 2024 | 2.877B |
| March 21, 2024 | 2.879B |
| March 20, 2024 | 2.864B |
| March 19, 2024 | 2.889B |
| March 18, 2024 | 2.869B |
| March 15, 2024 | 2.917B |
| March 14, 2024 | 2.871B |
| March 13, 2024 | 2.871B |
| March 12, 2024 | 2.878B |
| March 11, 2024 | 2.828B |
| March 08, 2024 | 2.840B |
| March 07, 2024 | 2.881B |
| March 06, 2024 | 2.801B |
| March 05, 2024 | 2.723B |
| March 04, 2024 | 2.801B |
| March 01, 2024 | 2.873B |
| February 29, 2024 | 2.743B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.823B
Minimum
Sep 27 2022
5.911B
Maximum
Jun 07 2021
3.828B
Average
3.611B
Median
Jun 17 2020
Market Cap Benchmarks
| Abliva AB | 13.44M |
| Karolinska Development AB | 69.51M |
| Calliditas Therapeutics AB | 545.58M |
| Oncopeptides AB | 23.97M |
| Olink Holding AB | 2.911B |
Market Cap Related Metrics
| PE Ratio | 20.15 |
| PS Ratio | 1.589 |
| PEG Ratio | 0.3079 |
| Price to Book Value | 2.776 |
| Price to Free Cash Flow | 18.83 |
| Price | 7.155 |
| Earnings Yield | 4.96% |
| PEGY Ratio | 0.2937 |
| Operating PE Ratio | 11.68 |
| Normalized PE Ratio | 20.15 |